ACSL4 and nasopharyngeal carcinoma: The expression of ACSL4 mRNA after LBH589 treatment was detected in NPC cells, and it was found that the mRNA level of ACSL4 did not change significantly (Fig. S2B), suggesting that LBH589 affects ACSL4 protein expression through PTM.